Schedule 13G ownership disclosure
VERTEX PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 92532F100
Event date: 2017-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,384,194
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-18-000215
- Form type
- SC 13G
- Filer
- VERTEX PHARMACEUTICALS INC / MA
- CIK
- CIK 875320
- Filed
- Feb 08, 2018
- Reporting period
- Dec 29, 2017
- Description
- Schedule 13G beneficial ownership